Surgery News

WASHINGTON — Tranexamic acid administered intravenously before and after noncardiac surgery lowered the risk for life-threatening, major and critical organ bleeding compared with placebo, according to results of the POISE-3 trial.

Edwards Lifesciences announced the FDA approved the Mitris Resilia surgical valve, a tissue valve replacement specifically designed for the heart's mitral position.

A novel, interdisciplinary limb salvage team reevaluating severe cases of critical limb ischemia avoided amputation for 75% of patients 180 days after revascularization, according to findings from a small study.

Comorbid peripheral artery disease is a significant risk factor for adverse events for patients with acute MI with cardiogenic shock, including worse limb outcomes and poorer short- and long-term survival compared with those without PAD.

Charles D. Fraser Jr., MD, a congenital heart surgeon, has been named as the inaugural executive director of the Institute for Cardiovascular Health, according to a press release.

Data show nonagenarians who underwent open heart surgery experienced no difference in operative mortality or in-hospital complications compared with octogenarians, researchers reported.

On Feb. 1, the first-in-human implantation of a novel miniaturized stent for infants and small children that can be expanded as they grew was performed at Children’s Hospital Los Angeles.

Rates of reintervention and other outcomes varied widely across surgical aortic valve models, with the Perimount models having the best performance, researchers reported in JAMA Network Open.

A man who became the first in the world to receive a genetically modified pig’s heart has died 2 months after the procedure, according to a press release.

Models based on perioperative basic metabolic panel laboratory values performed well in predicting acute kidney injury at 72 hours and 14 days after cardiac surgery, researchers reported in JAMA.